A citation-based method for searching scientific literature

Kara J Wyant, Andrew J Ridder, Praveen Dayalu. Curr Neurol Neurosci Rep 2017
Times Cited: 45







List of co-cited articles
327 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
256
26


Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
Samuel Frank, Claudia M Testa, David Stamler, Elise Kayson, Charles Davis, Mary C Edmondson, Shari Kinel, Blair Leavitt, David Oakes, Christine O'Neill,[...]. JAMA 2016
99
15

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
526
15


Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
558
13

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
13

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
569
13

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Brinda Ravikumar, Coralie Vacher, Zdenek Berger, Janet E Davies, Shouqing Luo, Lourdes G Oroz, Francesco Scaravilli, Douglas F Easton, Rainer Duden, Cahir J O'Kane,[...]. Nat Genet 2004
13

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
895
11

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Holly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, Curt Mazur, Melissa M McAlonis, Kimberly A Pytel, Jonathan W Artates, Andreas Weiss, Seng H Cheng, Lamya S Shihabuddin,[...]. Neuron 2012
454
11

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
11

Huntington disease: pathogenesis and treatment.
Praveen Dayalu, Roger L Albin. Neurol Clin 2015
88
11

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
423
11

Huntington's disease.
Francis O Walker. Lancet 2007
11

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
8

CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.
Su Yang, Renbao Chang, Huiming Yang, Ting Zhao, Yan Hong, Ha Eun Kong, Xiaobo Sun, Zhaohui Qin, Peng Jin, Shihua Li,[...]. J Clin Invest 2017
159
8


Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
Justo Garcia de Yebenes, Bernhard Landwehrmeyer, Ferdinando Squitieri, Ralf Reilmann, Anne Rosser, Roger A Barker, Carsten Saft, Markus K Magnet, Alastair Sword, Asa Rembratt,[...]. Lancet Neurol 2011
111
8

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
123
8


Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease.
Daniel O Claassen, Benjamin Carroll, Lisa M De Boer, Eric Wu, Rajeev Ayyagari, Sanjay Gandhi, David Stamler. J Clin Mov Disord 2017
39
10

Chorea associated with Huntington's disease: to treat or not to treat?
Joseph Jankovic, Raymund A C Roos. Mov Disord 2014
34
11

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
Samuel Frank, David Stamler, Elise Kayson, Daniel O Claassen, Amy Colcher, Charles Davis, Andrew Duker, Shirley Eberly, Lawrence Elmer, Erin Furr-Stimming,[...]. JAMA Neurol 2017
25
16

Dopamine and glutamate in Huntington's disease: A balancing act.
Véronique M André, Carlos Cepeda, Michael S Levine. CNS Neurosci Ther 2010
94
8

Quadruple deep brain stimulation in Huntington's disease, targeting pallidum and subthalamic nucleus: case report and review of the literature.
D Gruber, A A Kuhn, T Schoenecker, U A Kopp, A Kivi, J Huebl, E Lobsien, B Mueller, G-H Schneider, A Kupsch. J Neural Transm (Vienna) 2014
32
12

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
215
8

Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
Maria Jimenez-Sanchez, Floriana Licitra, Benjamin R Underwood, David C Rubinsztein. Cold Spring Harb Perspect Med 2017
103
8

Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
Evandro F Fang, Yujun Hou, Konstantinos Palikaras, Bryan A Adriaanse, Jesse S Kerr, Beimeng Yang, Sofie Lautrup, Md Mahdi Hasan-Olive, Domenica Caponio, Xiuli Dan,[...]. Nat Neurosci 2019
413
8

The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
38
10

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
8

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
249
8

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
411
8

Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
Jodi L McBride, Mark R Pitzer, Ryan L Boudreau, Brett Dufour, Theodore Hobbs, Sergio R Ojeda, Beverly L Davidson. Mol Ther 2011
153
8


Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
6

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
133
6

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
Filipe B Rodrigues, Gonçalo S Duarte, João Costa, Joaquim J Ferreira, Edward J Wild. Mov Disord Clin Pract 2017
25
12

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
123
6

Corticostriatal synaptic adaptations in Huntington's disease.
Joshua L Plotkin, D James Surmeier. Curr Opin Neurobiol 2015
67
6

Impaired PGC-1alpha function in muscle in Huntington's disease.
Rajnish K Chaturvedi, Peter Adhihetty, Shubha Shukla, Thomas Hennessy, Noel Calingasan, Lichuan Yang, Anatoly Starkov, Mahmoud Kiaei, Milena Cannella, Jenny Sassone,[...]. Hum Mol Genet 2009
179
6

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
6

AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease.
Rafael P Vázquez-Manrique, Francesca Farina, Karine Cambon, María Dolores Sequedo, Alex J Parker, José María Millán, Andreas Weiss, Nicole Déglon, Christian Neri. Hum Mol Genet 2016
53
6



Circuits and circuit disorders of the basal ganglia.
Mahlon R DeLong, Thomas Wichmann. Arch Neurol 2007
632
6

A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.
Lars Wojtecki, Stefan J Groiss, Stefano Ferrea, Saskia Elben, Christian J Hartmann, Stephen B Dunnett, Anne Rosser, Carsten Saft, Martin Südmeyer, Christian Ohmann,[...]. Front Neurol 2015
37
8

Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.
M Jacobs, E P Hart, E W van Zwet, A R Bentivoglio, J M Burgunder, D Craufurd, R Reilmann, C Saft, R A C Roos. J Neurol 2016
21
14

A randomized trial of amantadine in Huntington disease.
Padraig O'Suilleabhain, Richard B Dewey. Arch Neurol 2003
68
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.